ALIBABA-CLOUD
18.9.2020 05:02:07 CEST | Business Wire | Press release
As the digital technology and intelligence backbone of Alibaba Group, Alibaba Cloud is experiencing continuous growth alongside its customers across different parts of the world. Over the years, it has made relentless efforts to serve clients from every industry, helping them accelerate their business development and navigate the challenges of these volatile times.
Cloud computing and AI technology have been shown to be the cornerstone for businesses seeking to be fully equipped in the digital era, especially following the global outbreak of COVID-19. At the 12th Apsara Conference: Leap into the Future of Digital Intelligence, customers from various sectors, including aviation, leisure and hospitality, education, and e-commerce and retail, share their growth and success stories achieved together with Alibaba Cloud.
“It is our utmost pleasure to see our customers experience a seamless transition into more digitalised operations,” said Selina Yuan, President for International Business, Alibaba Cloud Intelligence. “As a leading global cloud service provider, we take pride in supporting organizations leverage the advantages of our trusted cloud and AI technology, as they fully unlock the potential of their businesses and develop sustainable growth with us. We will continue to enhance our products and services as we leap into the future of digital intelligence.”
Soar higher
In the face of the complex challenges imposed by the spread of the COVID-19 pandemic and the resulting global travel restrictions, Garuda Indonesia (Garuda), the flag carrier of Indonesia that has been providing air transportation for the last 70 years, has chosen Alibaba Cloud as its trusted cloud service provider, as it is determined to implement digital transformation solutions that will enhance its agility and competitiveness in the aviation industry through improved, reliable and highly efficient IT operations.
Thanks to Alibaba Cloud’s robust database and network technology, as well as its IT architecture design service and advice on resource optimization, the airline has been able to significantly improve the performance and service reliability of its core applications, ranging from ticketing, onboarding, and crew management to customer membership management. Since the migration of its business-critical applications to Alibaba Cloud, Garuda has seen great network latency reduction and improved cost efficiency. The airline also takes a shorter time to release and deploy a new application and has enhanced the efficiency of its overall application operations.
Skip the queue
In Malaysia, Resorts World Genting’s upcoming outdoor theme park Genting SkyWorlds will adopt the Advanced Virtual Queue (VQ) Solution powered by Alibaba Cloud to enhance the customer experience. The VQ Solution is a comprehensive system that leverages Artificial Intelligence (AI) and integrates five algorithm modules – Dynamic VQ Slot Prediction, Dynamic Gamification Management, Itinerary Planning, Incentive Recommendation and Crowd Analysis and Prediction. These modules combine to enable more efficient crowd management and to reduce waiting times dynamically.
The solution will allow visitors to plan their entire experience from start to finish before they even reach the theme park. Visitors will be able to download the Genting SkyWorlds’ VQ Mobile App and purchase their tickets online at their convenience. Once the tickets are booked, the VQ Mobile App will allow visitors to plan their itinerary or provide them with an alternative optimised recommended itinerary to offer them a customised experience based on their preferences.
Learn without barriers
Rooted in Singapore, I Can Read (ICR) is an English literacy education service provider for kindergarten and elementary school students across 200 centers and schools in Asia and the Middle East. The organization promotes a uniquely structured curriculum to help children overcome difficulties in reading. One of the biggest challenges faced by the company during the COVID-19 pandemic was the closure of its learning centers in markets where face-to-face classes were prohibited. When trying to move the classes online, ICR encountered several technical barriers – for example, unstable Internet connectivity, the lack of a sound cloud infrastructure, and the need to manually migrate its student database to the designated e-learning platform and re-create more than 7,000 timetables.
To cope with these difficulties, ICR turned to Alibaba Cloud for support. By implementing relevant solutions, such as database storage on cloud and SMS service, the company managed to engage regional customers better with timelier updates on class changes and subsequent arrangements. This has effectively helped the company to stay focused on its business mission of delivering education through both online and offline channels.
Integrate the marketplace, offline and online
WEMART is one of the largest Asian supermarket chains in the Middle East. Its bricks and mortar storefronts have been seriously affected by the COVID-19 pandemic, while its online business volume has increased sharply, pressuring the company to better consolidate its offline and online resources and accelerate its digital transformation.
To power its next phase of growth, WEMART chose to tie up with Alibaba Cloud, which offered a comprehensive online-to-offline shopping solution that combines the strengths of an in-store experience with digital marketing, supporting the operation flow by managing payment gateways, transaction processing and customer membership. In addition, the customer experience was enhanced by other features that came with the solution. For example, the AliMe chatbot, an AI-powered virtual assistant, can handle 60-70% of consumer queries and after-sales service requests on a 24/7 basis, narrowing the communication gap between the retailer and its buyers and greatly improving both operational efficiency and consumer responsiveness.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (alibabacloud.com), the digital technology and intelligence backbone of Alibaba Group, is among the world’s top three IaaS providers, according to Gartner. It is also the largest provider of public cloud services in China, according to IDC. Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and public services. Alibaba Cloud is the official Cloud Services Partner of the International Olympic Committee.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200917006047/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom